EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Diagnostic accuracy of C-reactive protein for diabetic foot osteomyelitis: a retrospective study and meta-analysis of composite cut-off values

Lulu Liu, Jinzheng Hou, Yukun Tao, Guangxin Zhou, Li Xiao, Juan Li, Fang Liu, Shouzhen Quan, Qingzhu Zhang, Da Zhang

Journal of Wound Care · 2026-04-01 · 35 (Sup4a)

DOI: 10.12968/jowc.2025.0340 ↗
AbstractBibliografische Angaben

Abstract

Objective: To determine the composite cut-off value and diagnostic accuracy of C-reactive protein (CRP) for diabetic foot osteomyelitis (DFO). Method: A retrospective study of patients was combined with a meta-analysis. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Pooled sensitivity, specificity and area under the curve (AUC) were calculated via forest plots and summary receiver operating characteristic curves. A composite cut-off model was developed using R 4.4.3 (R Foundation for Statistical Computing, Austria). Results: The experimental cohort comprised 265 patients (204 with DFO and 61 without). The meta-analysis comprised 12 studies, including a total of 1828 patients. The retrospective cohort demonstrated that CRP achieved an AUC of 0.63 (95% confidence interval (CI): 0.55, 0.71) for diagnosing DFO, with an optimal cut-off value of 9.57mg/l (sensitivity 74%, specificity 53%). Meta-analysis revealed pooled sensitivity of 74% (63–83%) and specificity of 73% (65–79%) (AUC=0.79; 95%CI: 0.75, 0.82). The composite model suggested a CRP cut-off of 15.20mg/l (sensitivity 80%, specificity 53%). Conclusion: In this study, CRP demonstrated moderate diagnostic utility for DFO and could function as a screening adjunct.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →